ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/05/29 | 2,146 | 2,177 | 2,112 | 2,125 | -7 | -0.3% | 124,800 |
2020/05/28 | 2,148 | 2,148 | 2,089 | 2,132 | +12 | +0.6% | 64,300 |
2020/05/27 | 2,110 | 2,126 | 2,102 | 2,120 | -4 | -0.2% | 58,100 |
2020/05/26 | 2,116 | 2,129 | 2,082 | 2,124 | +17 | +0.8% | 60,200 |
2020/05/25 | 2,067 | 2,116 | 2,066 | 2,107 | +45 | +2.2% | 87,900 |
2020/05/22 | 2,222 | 2,222 | 2,059 | 2,062 | -128 | -5.8% | 218,100 |
2020/05/21 | 2,198 | 2,221 | 2,172 | 2,190 | +12 | +0.6% | 103,800 |
2020/05/20 | 2,182 | 2,183 | 2,141 | 2,178 | +4 | +0.2% | 64,400 |
2020/05/19 | 2,200 | 2,205 | 2,127 | 2,174 | -14 | -0.6% | 73,800 |
2020/05/18 | 2,140 | 2,190 | 2,140 | 2,188 | +57 | +2.7% | 73,800 |
2020/05/15 | 2,130 | 2,137 | 2,090 | 2,131 | +49 | +2.4% | 66,700 |
2020/05/14 | 2,113 | 2,120 | 2,082 | 2,082 | -26 | -1.2% | 35,200 |
2020/05/13 | 2,044 | 2,112 | 2,044 | 2,108 | +35 | +1.7% | 50,200 |
2020/05/12 | 2,073 | 2,095 | 2,061 | 2,073 | +10 | +0.5% | 30,900 |
2020/05/11 | 2,082 | 2,084 | 2,053 | 2,063 | -7 | -0.3% | 37,300 |
2020/05/08 | 2,070 | 2,070 | 2,032 | 2,070 | +35 | +1.7% | 59,700 |
2020/05/07 | 2,044 | 2,071 | 2,024 | 2,035 | -17 | -0.8% | 60,400 |
2020/05/01 | 2,067 | 2,092 | 2,042 | 2,052 | -39 | -1.9% | 48,200 |
2020/04/30 | 2,150 | 2,174 | 2,085 | 2,091 | -37 | -1.7% | 107,100 |
2020/04/28 | 2,110 | 2,138 | 2,086 | 2,128 | +24 | +1.1% | 47,000 |
2020/04/27 | 2,128 | 2,128 | 2,089 | 2,104 | -26 | -1.2% | 45,700 |
2020/04/24 | 2,120 | 2,144 | 2,106 | 2,130 | +17 | +0.8% | 82,700 |
2020/04/23 | 2,078 | 2,115 | 2,078 | 2,113 | +36 | +1.7% | 59,800 |
2020/04/22 | 2,041 | 2,092 | 2,041 | 2,077 | -2 | -0.1% | 60,500 |
2020/04/21 | 2,053 | 2,085 | 2,032 | 2,079 | +24 | +1.2% | 48,600 |
2020/04/20 | 2,045 | 2,071 | 2,030 | 2,055 | -19 | -0.9% | 63,100 |
2020/04/17 | 2,070 | 2,120 | 2,026 | 2,074 | +16 | +0.8% | 93,300 |
2020/04/16 | 2,019 | 2,058 | 1,989 | 2,058 | +20 | +1% | 74,600 |
2020/04/15 | 2,055 | 2,063 | 2,007 | 2,038 | +5 | +0.2% | 92,000 |
2020/04/14 | 2,049 | 2,069 | 2,023 | 2,033 | -1 | ±0% | 74,000 |
2020/04/13 | 2,045 | 2,061 | 2,017 | 2,034 | -4 | -0.2% | 46,000 |
2020/04/10 | 1,998 | 2,043 | 1,966 | 2,038 | +27 | +1.3% | 51,700 |
2020/04/09 | 1,990 | 2,023 | 1,952 | 2,011 | +8 | +0.4% | 77,000 |
2020/04/08 | 1,995 | 2,038 | 1,973 | 2,003 | +8 | +0.4% | 91,000 |
2020/04/07 | 2,023 | 2,056 | 1,955 | 1,995 | -28 | -1.4% | 65,600 |
2020/04/06 | 1,952 | 2,034 | 1,941 | 2,023 | +66 | +3.4% | 53,200 |
2020/04/03 | 1,956 | 2,056 | 1,938 | 1,957 | -49 | -2.4% | 40,100 |
2020/04/02 | 1,981 | 2,045 | 1,981 | 2,006 | -4 | -0.2% | 69,300 |
2020/04/01 | 2,053 | 2,090 | 1,997 | 2,010 | -78 | -3.7% | 63,300 |
2020/03/31 | 2,199 | 2,199 | 2,048 | 2,088 | -109 | -5% | 85,700 |
2020/03/30 | 2,119 | 2,197 | 2,090 | 2,197 | +57 | +2.7% | 142,700 |
2020/03/27 | 2,138 | 2,154 | 2,091 | 2,140 | +66 | +3.2% | 214,300 |
2020/03/26 | 1,950 | 2,080 | 1,900 | 2,074 | +123 | +6.3% | 126,700 |
2020/03/25 | 1,980 | 1,980 | 1,851 | 1,951 | +20 | +1% | 64,000 |
2020/03/24 | 1,944 | 1,979 | 1,846 | 1,931 | +27 | +1.4% | 126,300 |
2020/03/23 | 1,864 | 1,949 | 1,814 | 1,904 | +40 | +2.1% | 171,800 |
2020/03/19 | 1,800 | 1,927 | 1,761 | 1,864 | +113 | +6.5% | 140,400 |
2020/03/18 | 1,689 | 1,810 | 1,669 | 1,751 | +83 | +5% | 126,000 |
2020/03/17 | 1,500 | 1,685 | 1,472 | 1,668 | +139 | +9.1% | 144,000 |
2020/03/16 | 1,530 | 1,597 | 1,520 | 1,529 | -2 | -0.1% | 118,200 |
1101~
1150
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム